Skip to content

Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19

Cardiac Rehabilitation and Ongoing Physical Activity During the Coronavirus Disease (COVID-19) Pandemic: An Exploratory Mixed-Methods Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04501432
Acronym
CODIS
Enrollment
27
Registered
2020-08-06
Start date
2020-07-14
Completion date
2020-10-24
Last updated
2022-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Rehabilitation

Keywords

COVID-19, Exercise Tolerance, Physical Activity, Qualitative Interview, Secondary Prevention, Social Distancing

Brief summary

The current Coronavirus Disease 2019 (COVID-19) pandemic has resulted in extraordinary public health orders of social distancing and self-isolation, leading to widespread disruption and discontinuation of cardiac rehabilitation programmes and other social opportunities for cardiovascular disease (CVD) patients to exercise. In Austria, the government initiated drastic public health measures (national lockdown) on March 16, 2020, leading to closure of all outpatient cardiac rehabilitation facilities and restriction of inpatient rehabilitation to patients with urgent medical indications only. This study aims to explore the impact of COVID-19-related national lockdown and public health restrictions on cardiac rehabilitation patients, with respect to maintenance of physical activity for secondary CVD prevention. The study poses three research questions, which will be addressed in a mixed-methods study with sequential quantitative-qualitative (QUANT-QUAL) design: 1. What was the impact of the COVID-19-related lockdown on patients' physical activity and physical fitness levels? (QUANT stage) 2. What was the patient experience of the closure of group-based cardiac rehabilitation training due to COVID-19 public health restrictions? (QUAL stage) 3. Which insights and learning points may be drawn from patients' experiences during COVID-19 public health restrictions with respect to the provision of home-based digital support for physical activity? (QUAL stage) The study will recruit a cohort of up to 40 cardiac rehabilitation patients from one outpatient cardiac rehabilitation centre in Salzburg, Austria, whose rehabilitation programme was interrupted by COVID-19 public health orders, including lockdown. Patients will undergo re-assessment of physical fitness in cycle ergometry test and re-assessment of cardiovascular risk profile. This will be compared with patients' most recent available test results from before the COVID-19 lockdown (i.e. prior to mid-March 2020) from patient records. Additionally, patients will take part in a semi-structured qualitative interview in which they will be invited to reflect on their personal experiences during the COVID-19 lockdown and thereafter.

Interventions

OTHERNo intervention

This study does not include an intervention

Sponsors

Institute of Sports Medicine, Prevention and Rehabilitation, Salzburg, Austria
CollaboratorUNKNOWN
Ludwig Boltzmann Institute for Digital Health and Prevention
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Adults (18 years and over) * Cardiovascular disease (CVD) * Currently enrolled in outpatient cardiac rehabilitation training at the study site * Informed consent

Exclusion criteria

* Contraindications for cardiopulmonary exercise testing * Pathologies limiting exercise performance * Pregnancy or breastfeeding * Limited German language

Design outcomes

Primary

MeasureTime frameDescription
Work load (W)up to 12 monthsMaximal work load (W) achieved in cycle ergometry test
Work load % of predicted valueup to 12 monthsMaximal work load (W) achieved in cycle ergometry test expressed as percentage of predicted value
Heart rate (bpm)up to 12 monthsMaximal heart rate (bpm) during cycle ergometry test
Framingham Recurrent Coronary Heart Disease risk scoreup to 12 monthsRange 1% to 29%, higher percentage indicating worse risk estimate

Secondary

MeasureTime frameDescription
Metabolic Equivalent (MET) minutes / weekup to 12 monthsMET-minutes/week calculated from patient self-report of physical activity (International Physical Activity Questionnaire, IPAQ, 7 day version)
Patient Experience5 monthsSemi-structured qualitative interview

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026